One in 10 countries have adequate protection against a 'catastrophic' biological event

Fewer than one-in-10 countries have met global standards for securing high-consequence pathogens, increasing risks of an accidental disease outbreak or bioterrorism, a campaign group has warned. Just 19 countries completing a United Nations safety check have built or shown strong biosecurity safeguards.

Statement from FDA Commissioner Scott Gottlieb, M.D., and Deputy Commissioner Anna Abram on the FDA’s new plan to advance plant, animal biotechnology innovation

The new plan advances policy priorities that the US Food and Drug Administration (FDA) will pursue to clarify their science-and-risk-based approach for product developers; avoid unnecessary barriers to future innovation in plant and animal biotechnology; and advance safety.